AI And Healthcare: Is The Bloom Finally Off The Rose?

What a rough few weeks it's been for AI and healthcare. In just the last ten days, we've seen the publication of a number of commentaries that collectively express a significant degree of caution, if not outright concern, about the extravagant expectations around the application of AI to healthcare and drug discovery. Let's start with the two peer-reviewed publications, both in the journal Digital Medicine. The first DM paper centers around "The'inconvenient truth' about AI in healthcare" – basically, the disconnect between promising research algorithms and the activity of frontline clinicians. In addition, Panch is the CMO of the company Wellframe, Mattie is affilitated with Welframe, and Celi is also associated with MIT.) Panch et al argue the disconnect stems from two factors: The authors highlight the potential of cloud computing, and argue the opportunity to benefit from this capability is thwarted by EMRs.